InVivo Biosystems

📍 Eugene, United States🗓 Founded 2011👥 63 employees💰 Last funded Mar 2019
Biotechnology Research🌐 invivobiosystems.com
Website LinkedIn
Our mission is to accelerate deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies. Our unique living platforms and technologies bridge the gap between cells and mice, providing faster, cost-effective investigations that focus on proof-of-principle experiments for rapid go/no-go decision making and advance the discovery and early-stage development of new compounds. InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts.
4
Total investors
0
Early stage
0
Mid stage
4
Late stage
2011
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2017–2019 · investors recorded per year
2017220192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in InVivo Biosystems?
InVivo Biosystems has 4 investors on record on gritt.io and 4 late-stage investors.
When did InVivo Biosystems last raise funding?
The most recent investment in InVivo Biosystems recorded on gritt.io was in March 2019.
When was InVivo Biosystems founded?
InVivo Biosystems was founded in 2011.
What industry is InVivo Biosystems in?
InVivo Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is InVivo Biosystems based?
InVivo Biosystems is headquartered in Eugene, United States.